Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 12, Pages 103442
Publisher
Elsevier BV
Online
2021-11-14
DOI
10.1016/j.isci.2021.103442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer
- (2021) Christopher J. Bergin et al. ONCOGENE
- Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
- (2020) Je-Hwan Lee et al. Blood Advances
- The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
- (2020) Janine Wörthmüller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells
- (2019) Evelyne Lima-Fernandes et al. Nature Communications
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Selective Wnt/β-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer
- (2019) JIN YOUNG KIM et al. ANTICANCER RESEARCH
- Cancer modeling meets human organoid technology
- (2019) David Tuveson et al. SCIENCE
- QMEANDisCo – Distance Constraints Applied on Model Quality Estimation
- (2019) Gabriel Studer et al. BIOINFORMATICS
- Knockdown of laminin α5 stimulates intestinal cell differentiation
- (2018) Manon Lepage et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- OUP accepted manuscript
- (2018) BIOINFORMATICS
- Peptidomimetic blockade of MYB in acute myeloid leukemia
- (2018) Kavitha Ramaswamy et al. Nature Communications
- Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
- (2018) Allison L. Boyd et al. CANCER CELL
- Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences
- (2018) Anqi Zhu et al. BIOINFORMATICS
- FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules
- (2018) Hongyi Zhou et al. Journal of Chemical Information and Modeling
- Multifaceted Interpretation of Colon Cancer Stem Cells
- (2017) Yuichiro Hatano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing
- (2017) Miguel Crespo et al. NATURE MEDICINE
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
- (2017) Yuko Tokunaga et al. Scientific Reports
- CWP232228 targets liver cancer stem cells through Wnt/β‑catenin signaling: a novel therapeutic approach for liver cancer treatment
- (2016) Ji‑Young Kim et al. Oncotarget
- Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation
- (2016) Kai Fu et al. eLife
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin
- (2015) King Chi Chan et al. Scientific Reports
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Molecular Pathways: Epigenetic Modulation of Wnt-Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells
- (2014) Y. D. Benoit et al. CLINICAL CANCER RESEARCH
- The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
- (2014) M. D. Arensman et al. MOLECULAR CANCER THERAPEUTICS
- Self-renewal as a therapeutic target in human colorectal cancer
- (2013) Antonija Kreso et al. NATURE MEDICINE
- Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
- (2012) Eleftherios Sachlos et al. CELL
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Template-based protein structure modeling using TASSERVMT
- (2011) Hongyi Zhou et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Cooperation between HNF-1α, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line
- (2010) Yannick D. Benoit et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Expression and Cytoplasmic Localization of SAM68 Is a Significant and Independent Prognostic Marker for Renal Cell Carcinoma
- (2009) Z. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- An Adaptor Role for Cytoplasmic Sam68 in Modulating Src Activity during Cell Polarization
- (2009) M.-E. Huot et al. MOLECULAR AND CELLULAR BIOLOGY
- Characterization of human embryonic stem cells with features of neoplastic progression
- (2009) Tamra E Werbowetski-Ogilvie et al. NATURE BIOTECHNOLOGY
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started